| 000 | 00994 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250513095458.0 | ||
| 264 | 0 | _c19961125 | |
| 008 | 199611s 0 0 eng d | ||
| 022 | _a1660-8151 | ||
| 024 | 7 |
_a10.1159/000189069 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDuranay, M | |
| 245 | 0 | 0 |
_aPlasma levels of terminal complement complex in the evaluation of bioincompatibility. _h[electronic resource] |
| 260 |
_bNephron _c1996 |
||
| 300 |
_a331 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Letter | ||
| 650 | 0 | 4 | _aBiomarkers |
| 650 | 0 | 4 |
_aComplement Membrane Attack Complex _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMaterials Testing _xmethods |
| 650 | 0 | 4 |
_aRenal Dialysis _xadverse effects |
| 700 | 1 | _aOlmez, U | |
| 700 | 1 | _aTurgay, M | |
| 700 | 1 | _aSahin, M | |
| 700 | 1 | _aBali, M | |
| 700 | 1 | _aTapiş, Y | |
| 773 | 0 |
_tNephron _gvol. 73 _gno. 2 _gp. 331 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000189069 _zAvailable from publisher's website |
| 999 |
_c8770145 _d8770145 |
||